Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics Bio-Techne has entered into a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics Wuxi Co., Ltd, China. ...

Liwen Pei commented, "I am excited about the collaboration with Lisen. The emerging molecular diagnostic market requires technical innovation as well as first-class quality reagents on which to build these novel tests."

Ning Zhou added, "As a high-tech diagnostic development company, Lisen is at the forefront of the rapidly growing medical industry. It is believed that this collaboration with Bio-Techne will give full play to the technological advantages of both parties and accelerate the development and market promotion of new diagnostic products."

About Bio-Techne Corporation (NASDAQ: TECH )